Submission Details
| 510(k) Number | K252619 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2025 |
| Decision Date | February 20, 2026 |
| Days to Decision | 185 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K252619 is an FDA 510(k) clearance for the QSCHECK UISACR, a Enzymatic Method, Creatinine (Class II — Special Controls, product code JFY), submitted by Qstag, Inc. (Incheon, KR). The FDA issued a Cleared decision on February 20, 2026, 185 days after receiving the submission on August 19, 2025. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1225.
| 510(k) Number | K252619 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2025 |
| Decision Date | February 20, 2026 |
| Days to Decision | 185 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JFY — Enzymatic Method, Creatinine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1225 |